Thomas Haustein

914 total citations
16 papers, 680 citations indexed

About

Thomas Haustein is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Thomas Haustein has authored 16 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in Molecular Medicine. Recurrent topics in Thomas Haustein's work include Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Thomas Haustein is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Thomas Haustein collaborates with scholars based in Switzerland, United Kingdom and United States. Thomas Haustein's co-authors include Robert F. Miller, Benny Chain, Jhen Tsang, David R. Katz, Mahdad Noursadeghi, Didier Pittet, Stephan Harbarth, John C. Hartley, Nigel Klein and U. Thaker and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and PLoS Medicine.

In The Last Decade

Thomas Haustein

15 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Haustein Switzerland 10 280 190 135 114 102 16 680
Dante Bassetti Italy 20 647 2.3× 379 2.0× 157 1.2× 147 1.3× 65 0.6× 72 1.3k
Francesca Crea Italy 13 220 0.8× 213 1.1× 97 0.7× 79 0.7× 68 0.7× 21 612
Ali Hassoun United States 10 449 1.6× 208 1.1× 81 0.6× 57 0.5× 60 0.6× 42 784
Shellee A. Grim United States 18 420 1.5× 423 2.2× 139 1.0× 64 0.6× 169 1.7× 35 1.1k
João Paulo Telles Brazil 14 265 0.9× 138 0.7× 49 0.4× 34 0.3× 97 1.0× 53 661
Gunnar Jacobsson Sweden 19 564 2.0× 475 2.5× 105 0.8× 277 2.4× 67 0.7× 43 1.2k
Laurel C. Preheim United States 22 283 1.0× 687 3.6× 83 0.6× 105 0.9× 218 2.1× 51 1.3k
Giovanni Gesu Italy 15 213 0.8× 201 1.1× 79 0.6× 42 0.4× 70 0.7× 33 576
I.M. Gould United Kingdom 14 317 1.1× 271 1.4× 54 0.4× 51 0.4× 101 1.0× 30 651
Luis Eduardo López-Cortés Spain 17 419 1.5× 278 1.5× 74 0.5× 122 1.1× 96 0.9× 61 810

Countries citing papers authored by Thomas Haustein

Since Specialization
Citations

This map shows the geographic impact of Thomas Haustein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Haustein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Haustein more than expected).

Fields of papers citing papers by Thomas Haustein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Haustein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Haustein. The network helps show where Thomas Haustein may publish in the future.

Co-authorship network of co-authors of Thomas Haustein

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Haustein. A scholar is included among the top collaborators of Thomas Haustein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Haustein. Thomas Haustein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Landelle, Caroline, Elodie von Dach, Thomas Haustein, et al.. (2015). Randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy of polyhexanide for topical decolonization of MRSA carriers. Journal of Antimicrobial Chemotherapy. 71(2). 531–538. 15 indexed citations
2.
Dach, Elodie von, Caroline Landelle, Thomas Haustein, et al.. (2015). Determinants of successful mrsa decolonization among patients included in a clinical trial of polyhexanide. Antimicrobial Resistance and Infection Control. 4(S1). 1 indexed citations
3.
Huttner, Benedikt, Thomas Haustein, Ilker Uçkay, et al.. (2013). Decolonization of intestinal carriage of extended-spectrum  -lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. Journal of Antimicrobial Chemotherapy. 68(10). 2375–82. 73 indexed citations
4.
Agostinho, Américo, Gesuèle Renzi, Thomas Haustein, et al.. (2013). Epidemiology and acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a septic orthopedic ward. SpringerPlus. 2(1). 91–91. 18 indexed citations
5.
Wernli, Didier, Thomas Haustein, & Stephan Harbarth. (2011). The European approach to antimicrobial resistance: success stories and challenges. Archive ouverte UNIGE (University of Geneva). 1 indexed citations
6.
Haustein, Thomas, et al.. (2011). Should this event be notified to the World Health Organization? Reliability of the International Health Regulations notification assessment process. Bulletin of the World Health Organization. 89(4). 296–303. 7 indexed citations
7.
Wernli, Didier, Thomas Haustein, John Conly, et al.. (2011). A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance. PLoS Medicine. 8(4). e1001022–e1001022. 67 indexed citations
8.
Haustein, Thomas, Petra Gastmeier, Alison Holmes, et al.. (2011). Use of benchmarking and public reporting for infection control in four high-income countries. The Lancet Infectious Diseases. 11(6). 471–481. 88 indexed citations
9.
Wernli, Didier, Thomas Haustein, John Conly, & Stephan Harbarth. (2011). Can the application of the international health regulations to antimicrobial resistance events help to preserve antimicrobials?. BMC Proceedings. 5(S6). 1 indexed citations
10.
Harbarth, Stephan & Thomas Haustein. (2010). Year in review 2009: Critical Care - infection. Critical Care. 14(6). 240–240. 4 indexed citations
11.
Emonet, Stéphane, et al.. (2010). Unusual primary HIV infection with colonic ulcer complicated by hemorrhagic shock: a case report. Journal of Medical Case Reports. 4(1). 279–279.
12.
Haustein, Thomas, John Harris, Richard Pebody, & Ben Lopman. (2009). Hospital Admissions Due to Norovirus in Adult and Elderly Patients in England. Clinical Infectious Diseases. 49(12). 1890–1892. 39 indexed citations
13.
Haustein, Thomas, Deborah Ridout, John C. Hartley, et al.. (2009). The Likelihood of an Indeterminate Test Result from a Whole-Blood Interferon-γ Release Assay for the Diagnosis of Mycobacterium tuberculosis Infection in Children Correlates With Age and Immune Status. The Pediatric Infectious Disease Journal. 28(8). 669–673. 137 indexed citations
14.
Sutherland, Colin J., Helen Fifer, Richard Pearce, et al.. (2009). Novel pfdhps Haplotypes among Imported Cases of Plasmodium falciparum Malaria in the United Kingdom. Antimicrobial Agents and Chemotherapy. 53(8). 3405–3410. 49 indexed citations
15.
Sutherland, Colin J., Thomas Haustein, Nahla B. Gadalla, et al.. (2007). Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis. Journal of Antimicrobial Chemotherapy. 59(6). 1197–1199. 36 indexed citations
16.
Noursadeghi, Mahdad, Jhen Tsang, Thomas Haustein, et al.. (2007). Quantitative imaging assay for NF-κB nuclear translocation in primary human macrophages. Journal of Immunological Methods. 329(1-2). 194–200. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dante Bassetti Breakdown of academic impact, for papers by Francesca Crea Breakdown of academic impact, for papers by Ali Hassoun Breakdown of academic impact, for papers by Shellee A. Grim Breakdown of academic impact, for papers by João Paulo Telles Breakdown of academic impact, for papers by Gunnar Jacobsson Breakdown of academic impact, for papers by Laurel C. Preheim Breakdown of academic impact, for papers by Giovanni Gesu Breakdown of academic impact, for papers by I.M. Gould Breakdown of academic impact, for papers by Luis Eduardo López-Cortés
Rankless by CCL
2026